Literature DB >> 23082103

Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Leanne B Josefsen1, Ross W Boyle.   

Abstract

Porphyrinic molecules have a unique theranostic role in disease therapy; they have been used to image, detect and treat different forms of diseased tissue including age-related macular degeneration and a number of different cancer types. Current focus is on the clinical imaging of tumour tissue; targeted delivery of photosensitisers and the potential of photosensitisers in multimodal biomedical theranostic nanoplatforms. The roles of porphyrinic molecules in imaging and pdt, along with research into improving their selective uptake in diseased tissue and their utility in theranostic applications are highlighted in this Review.

Entities:  

Keywords:  imaging; nanoagents; phototherapy; tetrapyrrolic photosensitisers; theranostics

Year:  2012        PMID: 23082103      PMCID: PMC3475217          DOI: 10.7150/thno.4571

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  415 in total

Review 1.  Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility.

Authors:  Rachel K O'Reilly; Craig J Hawker; Karen L Wooley
Journal:  Chem Soc Rev       Date:  2006-10-02       Impact factor: 54.564

2.  Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic resonance imaging studies.

Authors:  Si-Han Wu; Yu-Shen Lin; Yann Hung; Yi-Hsin Chou; Yi-Hua Hsu; Chen Chang; Chung-Yuan Mou
Journal:  Chembiochem       Date:  2008-01-04       Impact factor: 3.164

Review 3.  Photosensitization reactions in vitro and in vivo.

Authors:  Bonnie I Kruft; Alexander Greer
Journal:  Photochem Photobiol       Date:  2011-10-03       Impact factor: 3.421

4.  The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma.

Authors:  Monica Camerin; Michela Magaraggia; Marina Soncin; Giulio Jori; Miguel Moreno; Isabelle Chambrier; Michael J Cook; David A Russell
Journal:  Eur J Cancer       Date:  2010-03-29       Impact factor: 9.162

5.  Zn(II)-phthalocyanines as phototherapeutic agents for cutaneous diseases. Photosensitization of fibroblasts and keratinocytes.

Authors:  Clara Fabris; Marina Soncin; Giovanni Miotto; Lia Fantetti; Giacomo Chiti; Donata Dei; Gabrio Roncucci; Giulio Jori
Journal:  J Photochem Photobiol B       Date:  2006-01-19       Impact factor: 6.252

6.  Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).

Authors:  S G Rockson; P Kramer; M Razavi; A Szuba; S Filardo; P Fitzgerald; J P Cooke; S Yousuf; A R DeVault; M F Renschler; D C Adelman
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

7.  Photodynamic therapy with Pc 4 induces apoptosis of Candida albicans.

Authors:  Minh Lam; Paul C Jou; Ali A Lattif; Yoojin Lee; Christi L Malbasa; Pranab K Mukherjee; Nancy L Oleinick; Mahmoud A Ghannoum; Kevin D Cooper; Elma D Baron
Journal:  Photochem Photobiol       Date:  2011-06-13       Impact factor: 3.421

8.  Photodynamic properties of naphthosulfobenzoporphyrazines, novel asymmetric, amphiphilic phthalocyanine derivatives.

Authors:  P Margaron; R Langlois; J E van Lier; S Gaspard
Journal:  J Photochem Photobiol B       Date:  1992-07-15       Impact factor: 6.252

Review 9.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

10.  Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment.

Authors:  Liping Song; Hui Li; Ulas Sunar; Juan Chen; Ian Corbin; Arjun G Yodh; Gang Zheng
Journal:  Int J Nanomedicine       Date:  2007
View more
  85 in total

Review 1.  Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.

Authors:  Sunaina Singh; Amit Aggarwal; N V S Dinesh K Bhupathiraju; Gianluca Arianna; Kirran Tiwari; Charles Michael Drain
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 2.  Recent applications of phthalocyanines and naphthalocyanines for imaging and therapy.

Authors:  Yumiao Zhang; Jonathan F Lovell
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-07-20

3.  Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer.

Authors:  Jaehee Choi; Hyunjin Kim; Yongdoo Choi
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 4.  Green and Red Fluorescent Dyes for Translational Applications in Imaging and Sensing Analytes: A Dual-Color Flag.

Authors:  Elisabete Oliveira; Emilia Bértolo; Cristina Núñez; Viviane Pilla; Hugo M Santos; Javier Fernández-Lodeiro; Adrian Fernández-Lodeiro; Jamila Djafari; José Luis Capelo; Carlos Lodeiro
Journal:  ChemistryOpen       Date:  2017-11-07       Impact factor: 2.911

5.  Radioactive (90Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer.

Authors:  Evgenii L Guryev; Natalia O Volodina; Natalia Y Shilyagina; Sergey V Gudkov; Irina V Balalaeva; Arthur B Volovetskiy; Alexander V Lyubeshkin; Alexey V Sen'; Sergey A Ermilov; Vladimir A Vodeneev; Rem V Petrov; Andrei V Zvyagin; Zhores I Alferov; Sergey M Deyev
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-07       Impact factor: 11.205

6.  Theranostics and contrast-agents for medical imaging: a pharmaceutical company viewpoint.

Authors:  Jean-Marc Idée; Stéphanie Louguet; Sébastien Ballet; Claire Corot
Journal:  Quant Imaging Med Surg       Date:  2013-12

Review 7.  Porphyrins as ligands for 64copper: background and trends.

Authors:  Edgar Aguilar-Ortíz; Amir R Jalilian; Miguel A Ávila-Rodríguez
Journal:  Medchemcomm       Date:  2018-08-17       Impact factor: 3.597

Review 8.  Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents.

Authors:  Nela Malatesti; Ivana Munitic; Igor Jurak
Journal:  Biophys Rev       Date:  2017-03-24

Review 9.  Luminescent silica nanoparticles for cancer diagnosis.

Authors:  W Arap; R Pasqualini; M Montalti; L Petrizza; L Prodi; E Rampazzo; N Zaccheroni; S Marchiò
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

10.  Effects of bovine serum albumin (BSA) on the excited-state properties of meso-tetrakis(sulfonatophenyl) porphyrin (TPPS4).

Authors:  Pablo J Gonçalves; Fabio C Bezerra; Luciane M Almeida; Lais Alonso; Guilherme R L Souza; Antonio Alonso; Sergio C Zílio; Iouri E Borissevitch
Journal:  Eur Biophys J       Date:  2019-09-23       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.